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Abstract 
Several authors have used the notion of causal specificity in order to defend non-parity about 
genetic causes (Waters 2007, Woodward 2010, Weber 2017, forthcoming). Non-parity in this 
context is the idea that DNA and some other biomolecules that are often described as 
information-bearers by biologists play a unique role in life processes, an idea that has been 
challenged by Developmental Systems Theory (e.g., Oyama 2000). Indeed, it has proven to be 
quite difficult to state clearly what the alleged special role of genetic causes consists in. In this 
paper, I show that the set of biomolecules that are normally considered to be information-
bearers (DNA, mRNA) can be shown to be the most specific causes of protein primary 
structure, provided that causal specificity is measured over a relevant space of biological 
possibilities, disregarding physical as well as logically possible states of the causal variables.  
 
1. Introduction 
The notion of causal specificity as it is discussed here was introduced by Woodward (2010) in 
an attempt to show that different classes of causes, for example in biology, differ with respect 
to how fine-grained the control over their effect variable is. The basic idea is that typical 
biological events such as the synthesis of a protein may have thousands of different causes, but 
for a large part of them the corresponding cause and effect variables take only a few different 
values, e.g., present or absent. Only a few select causes are such that their variable takes many 
different values, each value maps onto a different value of the effect variable and each value of 
the effect variable is caused by a distinct value of the cause variable.1 A cause is highly specific 
to the extent in which its variable as well as its effect variable take many different values and 
there is a bijective mapping (or something close to a bijection) between the values of the cause 
and effect variables, respectively. This would appear to be the case for DNA and mRNA, for 
example: Each molecule of a given length may take a vast number of different nucleotide 
sequences and there is a mapping sufficiently close to a bijection between, e.g., sets of DNA 
sequences and their primary RNA transcripts or between mRNA sequences and the set of 
corresponding amino acid sequences into which the gene expression machinery translates these 
nucleotide sequences (disregarding the redundancy of the genetic code). Put differently, by 
manipulating the nucleotide sequence of DNA or mRNA, we could make any arbitrary 
polypeptide of a given length. The same is not true for other biochemical constituents of the 
gene expression machinery: RNA polymerase, for example, will obviously affect whether 
protein is made in a cell and how rapidly, but you cannot manipulate the polypeptide sequence 
of the proteins made by tampering with the RNA polymerase. 
Thus, causal specificity appears to provide a basis for causal non-parity, in other words, 
a rebuttal of the much-discussed idea that genomic DNA is causally on a par with other factors 
																																																						
1 See Ross (forthcoming) for a discussion of the role of causal control in biochemistry.   
involved in the development of an organism, which is a central tenet of Developmental Systems 
Theory (cf. Oyama 2000, Griffiths and Gray 2005). However, as Weber (2017, forthcoming) 
has shown, DNA and mRNA are not the only causes that could be manipulated such as to realize 
a high level of causal specificity. If we could manipulate a cell's tRNA population such as to 
modify the tRNA-amino acid assignments (aka the genetic code) after each ribosome cycle, we 
could synthesize any arbitrary polypeptide from any arbitrary mRNA (even a very uniform one 
such as poly-U). The same is true for the enzymes that charge the tRNAs with amino acid 
residues, the aminoacyl tRNA synthases. We probably cannot experimentally realize such a 
contrived set of manipulations, but it is logically and physically possible. For this reason, causal 
specificity alone is insufficient for establishing non-parity.  
We could try to rescue causal non-parity within this framework by using Waters's (2007) 
notion of actual-difference making cause. For a causally relevant factor to qualify as actual-
difference making in Waters’s sense, there must be actual variation with respect to both the 
cause and effect variables in some specified population, and the variation in the cause variable 
must either fully or partly account for the variation in the effect variable. Waters has argued 
that biologists often foreground actual-difference making causes in their explanations. DNA, 
with its high tendency to mutate, is an actual-difference maker in many biological populations 
and is often highlighted in biological explanations for this reason. While other cellular 
components may also be actual-difference makers, for example, splice enzymes, DNA is a 
causally (more) specific actual-difference maker according to Waters. tRNA, by contrast, is not 
an actual-difference maker in many populations; because it doesn’t usually vary between cells 
or individuals2 and doesn’t account for differences in protein sequence. Thus, even if there exist 
hypothetical interventions on tRNA that make it an equally specific cause of protein sequence 
																																																						
2 tRNA does account for so called “deviant” genetic codes, for example, in trypanosomes or 
in mitochondria. But this doesn’t account for a lot of actual variation in protein sequences.  
as DNA, these interventions do not correspond to any actual differences in biological 
populations; this is why tRNA is not causally on a par with DNA (and usually not described as 
bearing genetic information).  
Actual-difference making may often be the reason why biologists foreground certain 
causes and background others. But it has a drawback: Actual-difference making is necessarily 
relative to the choice of a population of individuals. Only if there is actual variation in the 
relevant variable(s) in the population chosen, can there be actual-difference making causes. Of 
course, in real biological populations (of molecules, cells, or individuals) there normally is 
actual variation, such that Waters's concept gets a grip on the causes that are typically 
highlighted by biologists. However, there are also counterexamples. For example, mammalian 
reticulocytes (precursors to red blood cells) under some conditions make only one protein. 
Furthermore, there are experiments in which only one polypeptide is made. Waters will insist 
that if this were always the case, then there would be no reason for foregrounding DNA or 
mRNA; they would then merely look like some kind of mechanical scaffold for the polypeptide 
assembly. While this reply has some force, there are alternatives that avoid the population-
relativity of Waters's account. As Weber (2017, forthcoming) argues, DNA and mRNA differ 
from other causally highly specific factors (such as tRNA) in that they are subject to 
biologically normal variation. This is the kind of variation that is the result (or could be the 
result) of naturally occurring processes such as spontaneous mutation and that is consistent with 
the survival of the organisms under consideration. 
In this paper, I would like to propose an alternative approach to establishing non-parity 
with the help for causal specificity, namely a modal approach.3 In a nutshell, I will argue that 
causal specificity should be measured over a suitable modal space of biological possibilities.  
In the following Section, I will expose in somewhat greater detail the problem of how 
to measure causal specificity. In Section 3, I will introduce the concept of biological modality 
that I will use. In Section 4, I show how a modal restriction on causal specificity makes precisely 
those biological causes stand out that biologists normally refer to as information-bearers. In 
Section 5, I try to draw together some lose ends. 
 
2. Causal Specificity: What Should We Measure? 
Causal specificity was introduced by Woodward (2010) in order to distinguish between such 
causes that allow some kind of fine-grained control over their effects and such cases that 
influence their effect variables more crudely, in the extreme case just like an on-off switch. His 
account of causal specificity is modeled on Lewis's (2000) concept of influence, with some 
modifications: 
 
(INF) There are a number of different possible states of C (C1… Cn), a number of 
different possible states of E (E1… Em) and a mapping F from C to E such that for many 
states of C each such state has a unique image under F in E (that is, F is a function or 
close to it, so that the same state of C is not associated with different states of E, either 
on the same or different occasions), not too many different states of C are mapped onto 
the same state of E and most states of E are the image under F of some state of C. This 
																																																						
3 Weber's (2017, forthcoming) approach is also modal because it appeals to what could be 
caused by natural processes. However, biological normality is a difficult concept and it is 
therefore worth examining if there isn’t a clearer modal criterion. 
mapping F should describe patterns of counterfactual dependency between states of C 
and states of E that support interventionist counterfactuals. Variations in the time and 
place of occurrence of the various states of E should similarly depend on variations in 
the time and place of occurrence of states of C (Woodward 2010, p. 305). 
 
With respect to Lewis (2000), Woodward has made two modifications: One change concerns 
the purpose. While Lewis introduced influence in order to define causality, Woodward only 
wants to distinguish between different kinds of causes, which are antecedently defined in 
interventionist terms.4 The second modification is a simplification: Lewis required that the 
different values of the cause and effect variables be close to each other, thus requiring only 
minute changes to be actualized. This requirement doesn't appear in Woodward's account. The 
approach outlined here could be seen as reintroducing it, or at least something similar. 
 Woodward (2010) suggested that causal specificity distinguishes some biological 
causes from others. For example, among the many different causal factors that are involved in 
protein synthesis, the genes appear to be the most specific ones because there are many different 
possible DNA sequences that can give rise to zillions of different protein molecules. In a similar 
way, Waters (2007) has argued that some actual-difference making causes (a technical notion 
that he introduced himself, see Section 1) are highly specific while others are non-specific. For 
example, alternative splicing controlled by spliceosome complexes in eukaryotic cells (usually) 
has only a few possible states that map into a small set of different polypeptides. By contrast, 
genes have a vast amount of specificity with respect to protein sequence.  
 Griffiths et al. (2015) have called Waters's conclusion with respect to the comparative 
specificity of DNA and splice agents into question. They point out that there exist cases of 
alternative splicing with more than 38'000 different splice variants. In order to allow 
																																																						
4 For an approach that combines these two objectives see Strand and Oftedal (2017). 
quantitative comparisons of causal specificity, they have introduced an information-theoretic 
measure, namely mutual information. Briefly, they define the specificity of a causal relation as 
the difference in Shannon-entropy of the effect variable before and after the cause variable has 
been set to a specific value by an intervention. They then show that causal specificity so defined 
is about of the same order of magnitude for alternative splicing and for actual DNA variation 
in select biological systems. 
 As Weber (2017) shows, Griffiths et al. (2015) misconstrue Waters's (2007) notion of 
causally specific actual-difference maker. The way in which they apply their information 
measure to the examples, they take into account only the actual variation in cause and effect 
variables in specific systems. While, on Waters's account, actual variation in a population is 
indeed necessary for the existence of actual-difference makers in this population, causal 
specificity as Waters uses it (namely in Lewis's sense of influence) is a property of a range of 
possible values of the variables in question. Thus, what matters according to Waters is the 
specificity of the potential variation of the actual-difference makers, and not of the actual 
variation of the actual difference-makers, which is what Griffiths et al. are comparing. 
 While information theory may be a useful resource for studying causality in biology, 
for the purposes of my argument we don't really need it. In what follows, I will only need a 
quantity that I will refer to as "range of causal influence", which is simply the number of 
possible values of a variable for which there is an invariant causal dependence relation plus a 
bijective or near-bijective mapping of the possible states of the cause and effect variables. I 
shall henceforward refer to this quantity as “RCI specificity”. This is one of two components 
of causal specificity, the other being the closeness of an invariance relation to a bijection. We 
could measure these quantities in terms of information as Griffiths et al. (2015) do, but since 
it's not necessary for my argument I will stay clear of the concept of information and the whole 
technical apparatus of information theory, as it would only introduce additional difficulties. 
 The crucial question is what values of a causal variable should be taken into account for 
measuring RCI specificity. At first glance there are two options: 
(1) All realized values in some actual population 
(2) All values possible in any population 
Let us consider these two options. 
 Option (1). If we count only the values the are actualized in some real population, there 
will be lots of populations for which the specificity is higher for processes such as alternative 
splicing etc. than it is for the molecules that biologists refer to as information-bearers (DNA 
and mRNA). Griffiths et al. (2015) make that case convincingly. If the goal is to find a special 
causal role played by genes then we must take a different approach. Perhaps option (2)? 
 Option (2). This option consists in counting all the possible values that a causal variable 
my take in any population when determining its range of causal influence. For the case of DNA-
protein, this could mean all the possible DNA-sequences that can give rise to a polypeptide of 
a given length. (I assume that this corresponds to the INF property used by Woodward and 
Waters). Obviously, this will return gigantic numbers for DNA sequence variation (e.g., there 
are 41000 possible DNA strings of 1kb length). However, here we must be careful what exactly 
we mean by "possible values" for a causal variable. Without any constraints on possibility, we 
risk counting a lot of highly remote or even weird and gerrymandered possibilities. Remote 
possibilities would be such possibilities that could never be realized or would take too much 
time to evolve (see Griffiths et al. 2015, 545).  
 For a gerrymandered case, consider a scenario involving protein synthesis where the 
assignment of transfer-RNA (tRNA) and amino acid and hence the genetic code changes after 
each elongation step of the ribosome, i.e., after each new peptide bond formed by the ribosome. 
In other words, we take as possible values of the cause variable complex time-dependent 
functions that indicate different tRNA populations at different times during the ribosome 
elongation cycle. In this way, we could generate any arbitrary amino acid sequence from any 
given mRNA sequence (even degenerate sequences such as poly-U or poly-A). In other words, 
the causal specificity of tRNA would match that of mRNA. Alternatively, we could imagine a 
change by intervention on the substrate specificity of aminoacyl-tRNA synthase after each 
elongation step in protein synthesis, which would also amount to a modification of the genetic 
code. In this way, too, we end up with a vast causal specificity for a molecule that is not 
normally considered as an information-bearer. 
 It should be noted that such weird and gerrymandered scenarios are ruled out if we apply 
Waters's criterion of actual-difference making. This notion requires that there be actual 
variation in a cause variable in some given population and that this actual variation account for 
the actual variation in the effect variable. However, this move will also rule out such 
populations where there is no actual genetic variation but where genes are playing the exact 
same role as in populations where there is variation. For this reason, we need a way of 
describing the causal role of genes that is less sensitive to the choice of a population. 
 I am going to argue that what is needed here is a restriction on the notion of possibility. 
We should calculate specificity not over any set of actualized values but over possible values 
of the causal variables, where the relevant sense of possibility should be neither logical 
possibility nor physical possibility – as they both permit the remote possibilities as well as weird 
and gerrymandered cases – but biological possibility instead. In other words, I am going to 
defend causal non-parity for DNA and mRNA by arguing that they have the highest RCI 
specificity at some relevant level of biological possibility. While this notion may appear elusive 
in light of the scant philosophical literature on the subject, there are attempts to explicate it. I 
will briefly introduce such an account in the following section.  
 
3. A Primer on Biological Modality 
It seems that most philosophers and biologists would accept the two following claims: (1) Every 
state of affairs that is biologically possible is physically possible, (2) not everything that is 
physically possible is biologically possible. An elephant with feathers would be physically 
possible but biologically impossible while a flying elephant would be both physically and 
biologically impossible (I guess). An immortal elephant is only biologically possible if it is 
physically possible. Similar claims could be made about necessity: It might not be physically 
necessary that an elephant show aging and senescence, but (so far as we know) it is biologically 
necessary.5  
 How should we think about such modalities? Are they features of organisms or of our 
knowledge? Do biological modalities come in degrees? Are they absolute or relative to specific 
lineages? And can there be a systematic theory about the validity of inferences involving such 
modalities and about the conditions under which modal claims are true or false? In what 
follows, I will ignore the question of whether modalities are about the objects of science or 
about our knowledge about them. By contrast, I will take a stance on the other questions: Yes, 
yes and yes: biological modalities come in degrees, they are lineage-relative and a logic of 
biological modalities is possible. To my knowledge, the first formal logic of biological 
modalities is due to Huber (2017). My considerations in this paper will be based on Huber’s 
modal logic, which I will slightly adapt to my purposes.  
 Huber’s logic refines and formalizes an idea presented by Dennett (1995). In order to 
conceptualize biological possibility, Dennett invented the "Library of Mendel", a library that 
contains all the genomes that can be constructed from the four DNA bases A, T, C and G. 
(Inspired from Jorge Luis Borges's "Library of Babel"). A "reader-constructor" maps genomes 
																																																						
5 According to some theories of the evolution of life histories, senescence has evolved due to 
selection pressures that limit the fitness contribution of genes that enhance survival late in 
life. There are also models that view senescence as an adaptation, however, most of them 
invoke constraints on natural selection to eradicate genes responsible for senescence or trade-
offs with other life history traits such as fecundity (Stearns 1992). 
from the Library of Mendel to phenotypes. Biological possibility is then defined by Dennett in 
terms of an accessibility relation for genomes: 
 
X is biologically possible iff X is an instantiation of an accessible genome or a feature 
of its phenotypic products. 
 
It is clear in Dennett's account that biological possibility is always relative to a given genome, 
g. A biological organism is possible at g to the extent in which it is the phenotypic product of a 
genome g' that is accessible from g (e.g., by a series of point mutations or sequence 
rearrangements). The more accessible g' is from g, the more possible is its phenotypic product 
at g.  
Dennett did not really specify the relevant accessibility relation. This is where Huber's 
(2017) account comes in. He first reformulates the Library of Mendel as a relational structure 
(61): 
 
The Library of Mendel is a relational structure 〈ΣM, RM〉 where the domain is the 
language of the Library of Mendel M and the binary relation is the accessibility 
relation RM. 
   
The language of the Library of Mendel consists of an alphabet containing the four nucleotide 
bases A, G, C and T. Biological possibility is then defined in terms of satisfaction of the binary 
relation (61): 
 
Some x is biologically possible at g ∈ ΣM if and only if there is some g' ∈ ΣM such that 
gRMg' and x is an instance of g' or a feature of the phenotypic products of g' 
 
Finally, Huber provides an interpretation of the accessibility relation RM: 
 
For g, g' ∈ ΣM, gRMg' if and only if there is a solution to a string editing problem with 
respect to g, g' 
 
A string editing problem is the problem of obtaining some string of symbols from another 
string by the least costly set of edit operations. For example, the string 'AACTTC' can be 
obtained from the string 'GGCTTC' by an edit operation that replaces all Gs in the string by 
As. The same sequence could also be obtained by first replacing all Cs by As, then change 
back all As to Cs, and finally replacing all Gs by As. Obviously, the latter edit operation 
would be more costly. For most cases, we can identify the number of edit steps needed with 
the cost, in order words, the cost of each step is identical. However, there might be cases 
where the cost varies with the kind of change introduced. For example, we could consider 
operations that cannot be brought about by an existing biological mechanisms as being more 
costly. Alternatively, we could make the edit cost depend on the amount of metabolic energy 
needed or on the fitness landscape. In any case, the solution to a string edit problem depends 
on the assumption of a cost function and space of biological possibility is going to be relative 
to such an assumption. 
 This formulation in terms of string editing allows Huber to use the string edit distance 
as a measure of possibility. Several such measures exist; for example, the Levensthein 
distance is defined as the minimal number of operations needed to transform one string into 
another. As new genomes arise by mutation and recombination of existing genomes, the 
number of such changes needed to obtain a new genome from an existing one seems like a 
biologically relevant measure of accessibility. 
 Thus, in brief, according to Huber the less mutational or recombinational steps are 
required to create a genome g' from an existing g, the more accessible and hence the more 
possible the latter is with respect to the former. This seems well in line with the intuition that, 
whatever biological possibility is, it must be relative to a given organism or lineage and it 
must admit of degrees.  
 In order to apply Huber’s modal theory to our problem, we need to widen its scope a 
little. In particular, we must allow strings that are not representations of DNA nucleotide 
sequences but of something else, e.g., tRNA populations or different states of an enzyme 
complex such as the spliceosome. Huber’s formalism doesn’t cover such cases and I will not 
attempt to provide a modified formalism, I will simply assume that this could be worked out 
formally. 
 
4. Causal Non-parity of DNA Mutation and Alternative Splicing as Causes of Protein 
Sequence Variation 
Using Huber's theory of biological possibility, we can easily show that there exists a kind of 
biological variation with high causal specificity that is (highly) biologically possible and that 
any variation with the same causal specificity is less biologically possible. 
In order to show this, Huber’s account of biological modality has to be adapted to 
structures other than genomes, that is, to such structures as they feature in the gerrymandered 
scenarios. In order to adapt it to the gerrymandered tRNA case, we need to replace the DNA 
strings by tRNA populations. Instead of a string editing problem (how can we obtain string g' 
from g?) we have the problem of how we have to modify a tRNA population such as to make 
a certain set of protein sequences. This is going to be costly because the tRNA population might 
have to be changed for each new amino acid added in order to obtain a causally highly specific 
mapping. 
In order to be clear about what exactly we are comparing, let us consider two DNA 
strings that code for a protein of 300 amino acids length. Furthermore, let us assume that these 
two strings are separated by an edit distance (Levensthein) of two, i.e., we allow two mutation 
steps. Let us count only those mutations that will cause single amino acid substitutions in two 
different positions in the corresponding proteins. This will yield 1/2(300 x 299)202 = 
22,111,200 different polypeptides. Thus, at this level of biological possibility – which appear 
quite high as two point mutations can easily occur in nature – we already have an RCI value 
corresponding to more than 22 million variants.  
Could we make a matching number of polypeptides in the gerrymandered tRNA 
scenario? Recall that the scenario is this: We keep the DNA and corresponding mRNA 
sequence constant and manipulate the genetic code (i.e., the codon or amino acid specificity of 
the tRNA population) wherever necessary to obtain all the possible polypeptide variants that 
show two amino acid substitutions in two different positions. In order to do so, we might have 
to replace the cell’s entire tRNA population several times as the elongation of the nascent 
polypeptide chain proceeds. It seems to me that, in this way, the entire 22 millions or so variants 
can be generated. Thus, the RCI specificity is the same. But note that this is more costly than if 
the same variety is generated by interventions on the DNA. For starters, it requires at least four 
interventions per polypeptide variant as opposed to two in the DNA case, because the tRNAs 
have to be changed back after each intervention such as to allow the rest of the sequence to be 
read off normally. Furthermore, we have to either replace all the tRNA molecules in the cell or, 
in a Maxwell’s demon kind of way, catch exactly those individual molecules that are about to 
deliver an amino acid moiety to the nascent chain. Even though this is not exactly the same 
kind of change as a series of string editing steps, it clearly is more difficult to bring about.6  
																																																						
6	So far as I know, there isn’t even a cellular mechanism that could carry out such an 
intervention, however, this isn’t relevant for the kind of biological possibility that I am after 
here. The point here is that, even if there were such a biological mechanism, it would be 
costlier than the mechanism required for generating the same variation by interventions at the 
DNA level.	
Thus, if we presuppose a ranking of biological possibility based on the number and cost 
of changes necessary to bring about a certain kind change, we can conclude that the 
interventions that would be necessary to realize the same range of causal influence as is inherent 
in genes and mRNA are less biologically possible.  
So far we have shown that there exists a level of biological possibility at which the most 
specific causes for protein sequence are DNA and mRNA. Now, in order to establish a kind of 
causal non-parity based on graded biological possibilities, we still have to show that the 
variability that can be generated at this possibility level by interventions on DNA/mRNA is 
actually greater than that of other specific causes of protein sequence, in particular alternative 
splicing. Let us consider the case of Drosophila DSCAM, also discussed by Griffiths et al. 
(2015) and Weber (2017). This locus is organized into 24 exons that can be combined in 
different ways such as to produce 38,016 different protein isoforms. In order to respect parity 
of reasoning, we might have to take into account not only the actual variants of this protein, but 
also potential variants that could result from interventions in the splice mechanism.  
 However, it should be noted that we cannot generate additional diversity by altering the 
splice signals, i.e., the sequences that direct the spliceosome complex to the splice sites and 
mark the intron/exon boundaries (see Alberts et al. 2015, 310-320, for details about splicing 
mechanisms). The reason is that, in order to count the potential variation of the splice 
mechanism itself we have to keep the DSCAM gene constant. Now, this gene is unlikely to 
contain another set of repeated signals that would be suitable for alternative splicing. Thus, if 
we wanted to generate more diversity by intervening on the splice mechanism, we would have 
to change the splice signals recognized by the spliceosome during the splicing process, i.e., in 
between different cuts made by the spliceosome. This could potentially produce a vast number 
of additional protein variants. 
I think it is clear that this would be another one of the weird cases analogous to the 
gerrymandered tRNA cases. As in the latter case, we could argue that bringing about the 
necessary changes in this way would be more costly than by simply mutating the DNA- or 
mRNA sequences by introducing two independent mutations. Thus, such modifications are less 
biologically possible than modifications of genes or mRNA. 
The upshot is that there exist levels of biological possibility at which genetic variation 
at the DNA or mRNA level has the greatest RCI specificity. In order to find variety generators 
of comparable specificity we always had to resort to scenarios that, on an account of biological 
possibility such as Huber’s, are much less biologically possible. This establishes a new kind of 
causal non-parity in the modal realm.  
 
5. Conclusions 
Recently, Griffiths et al. (2015) have developed a quantitative measure of causal specificity 
based on information theory and used it to criticize existing attempts to show that DNA and 
mRNA are causally more specific with respect to protein primary structure than, for example, 
alternative splicing. In particular, they argue that a measure that they call SAD and 
(erroneously) take to be a quantitative version of Waters’s notion of specific actual-difference 
making cause, gives similar values for genes and for some extreme cases of alternative splicing. 
In this paper, I have proposed a modal approach to defending causal non-parity against this 
challenge.  
 According to the measure developed by Griffiths et al., causal specificity is defined as 
the decrease in entropy or uncertainty about the value of an effect variable by setting the cause 
variable to a specific value by an intervention. There are two sets of issues that must be 
addressed separately in order to apply this measure to real cases. First, causal specificity is 
always relative to a probability distribution on the values of the two variables. Second, we must 
be explicit what the relevant domain of the cause variable (and thereby also of the effect 
variable) should be. This is basically the question of what kinds of interventions should be 
considered when measuring causal specificity. Obviously, the choice of domain can have as 
much an impact on the entropy of the variables and therefore on the causal specificity measure 
as the assumed probability distribution over the values of the variable.  
 In this paper, I have ignored issues having to do with the probability distribution of 
different values of causal variables in biology because these are hard to estimate. Instead, I have 
concentrated on what Woodward called range of causal influence or RCI for short. One 
advantage of RCI is that it is independent of the probability distribution of the causal variables. 
However, RCI is sensitive to different domain choices. I have focused on the following options 
for selecting a domain for determining RCI: (1) the set of all physically possible values, for 
example, on the coding sequence of a gene or the enzymatic specificity of the spliceosome 
complex (which mediates alternative splicing), (2) the set of all values that have a certain level 
of biological possibility in a given context, where biological possibility is understood along the 
lines discussed in Section 3.  
(1) In the case of genes, the set of all physically possible values will include all the 
possible permutations of A, G, T and C in a DNA sequence that defines a certain protein-coding 
gene. The resulting RCI with respect to protein sequence is vast, as without any constraints on 
the number of possible changes the RCI is given by the number of possible proteins of a given 
length, i.e., 20N if N is the number of amino acids. While this looks impressive, the set of all 
physically possible values is not a good choice of domain if the goal is defending causal non-
parity. The reason is that, as we have seen, this domain choice will also yield comparatively 
high values for biomolecules that are not usually considered to be information-bearers, such as 
tRNA (transfer-RNA) or the enzymes that charge tRNAs with amino acids in protein synthesis 
(aminoacyl tRNA-synthase). These are among the molecules that define the genetic code. 
Because it is physically possible to change that code after each chain elongation event due to 
an intervention, any arbitrary polypeptide could be made from any arbitrary DNA sequence. 
Thus, the causal specificity of these molecules matches that of DNA and mRNA. Thus, the set 
of all physically possible values will fail to single out just those molecules considered to be 
information-bearers with respect to protein sequence according to contemporary biology 
(usually DNA and mRNA). 
 (2) What about the set of all values that enjoy a certain level of biological possibility in 
a given context? Clearly, this domain choice will yield much lower RCI specificity figures for 
the DNA variable, because not all permutations of a gene are equally biologically possible to a 
given population. For example, biological possibility as understood in this paper is relative to 
evolutionary timescales. When we consider just a few generations, evolutionary processes such 
as point mutation can introduce considerable genetic variation into a population (actual or 
merely possible), but certainly not all combinatorially possible permutations of gene. But this 
is not necessary. Even if we allow only two independent amino acid substitutions in a 
polypeptide of 300 amino acids length, we already have an RCI value > 22 millions, as I have 
shown. This is considerably larger than the 38’000 or so protein isoforms that are possible due 
to alternative splicing. A greater causal specificity for alternative splicing is imaginable but not 
biologically possible, at least not at the same level of possibility as in the two DNA-point 
mutation scenario.  
 As I have argued, in calculating the causal specificity of alternative splicing over the 
some biologically possible domain, we have to disregard variation generated by modified splice 
recognition sequences. Alternative splicing depends on there being repeated splice signals in a 
primary transcript, and a given gene is unlikely to contain more than one set of repeated 
sequences that could serve as splice recognition signals.  
 To conclude, measuring the causal specificity of linear biomolecules over the set of the 
biologically possible instead of the physically possible interventions can yield non-parity of 
genetic causes compared to alternative splicing and other cellular mechanisms. This also 
confirms that causal explanations in biology sometimes implicitly appeal to biological 
modalities (Beatty 2016). 
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